Quick Answer
FILANA THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $95.50 million for the year ending 2025.
- FILANA THERAPEUTICS, INC. showed a decrease of -25.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from FILANA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), FILANA THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 37.6%.
- Historical annual values: Fiscal year 2025: $95.50 million | Fiscal year 2024: $128.57 million | Fiscal year 2023: $121.14 million | Fiscal year 2022: $201.02 million | Fiscal year 2021: $233.44 million | Fiscal year 2020: $93.51 million | Fiscal year 2019: $23.08 million | Fiscal year 2018: $19.81 million | Fiscal year 2017: $10.48 million | Fiscal year 2016: $16.62 million | Fiscal year 2015: $31.30 million | Fiscal year 2014: $40.59 million | Fiscal year 2013: $48.59 million | Fiscal year 2012: $49.36 million | Fiscal year 2011: $73.14 million | Fiscal year 2010: $4.80 million | Fiscal year 2009: $35.79 million | Fiscal year 2008: $153.16 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: